Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines01:30

Cancer Vaccines

910
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
910
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer.

Nanomedicine (London, England)·2026
Same author

A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.

Nanomedicine (London, England)·2026
Same author

miR-22-Galectin-1 as an integral signaling axis in regulating metabolism and immunity in HCC.

Biomarker research·2026
Same author

Designing Programmable Peptide Nucleic Acid-based Nanovaccines for Anticancer Immune Activation.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

My Perspective on OBOC Combinatorial Technology.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Planar, Kinked, or Twisted? Molecular Structures of Blue and Red Phase Polydiacetylene Langmuir Films.

Langmuir : the ACS journal of surfaces and colloids·2025

Related Experiment Video

Updated: Jan 4, 2026

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.6K

Peptide-based materials for cancer immunotherapy.

Lu Zhang1, Yanyu Huang1, Aaron Raymond Lindstrom1

  • 1Department of Biochemistry and Molecular Medicine, UC Davis NCI-designated Comprehensive Cancer Center, University of California Davis, Sacramento, California 95817, United States.

Theranostics
|November 8, 2019
PubMed
Summary
This summary is machine-generated.

Peptide-based immunotherapies show promise for cancer treatment by regulating immune responses. This review explores peptide cancer vaccine design, applications, and challenges for improved cancer immunotherapy.

Keywords:
Peptide-based materialscancer immunotherapy

More Related Videos

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.8K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.2K

Related Experiment Videos

Last Updated: Jan 4, 2026

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.6K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.8K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.2K

Area of Science:

  • Immunology
  • Oncology
  • Biomaterials Science

Background:

  • Peptide-based materials are promising for cancer immunotherapy.
  • Current research focuses on peptide vaccines and delivery systems mimicking protein functions.
  • A comprehensive understanding of peptide-immune system interactions is lacking.

Purpose of the Study:

  • To review the role of peptides in regulating innate and adaptive immune systems.
  • To provide a comprehensive focus on the design, categories, and applications of peptide-based cancer vaccines.
  • To elucidate the impact of peptide characteristics on immunogenicity for better utilization.

Main Methods:

  • Literature review of peptide-based cancer immunotherapy.
  • Analysis of peptide design, formulation, and immunomodulatory functions.
  • Discussion of challenges in large-scale synthesis, delivery, and clinical translation.

Main Results:

  • Peptides play a crucial role in modulating both innate and adaptive immunity.
  • Peptide length and formulation significantly impact immunogenicity.
  • Understanding these factors is key to optimizing peptide-based immunomodulating agents.

Conclusions:

  • Peptide-based cancer vaccines offer a promising avenue for cancer immunotherapy.
  • Further research is needed to address challenges in synthesis, delivery, and clinical application.
  • Optimizing peptide design and formulation can lead to significant breakthroughs in cancer treatment.